![Eosinophile Granulomatose mit Polyangiitis (EGPA) - Erkrankungen des rheumatischen Formenkreises und des Bewegungsapparats - MSD Manual Profi-Ausgabe Eosinophile Granulomatose mit Polyangiitis (EGPA) - Erkrankungen des rheumatischen Formenkreises und des Bewegungsapparats - MSD Manual Profi-Ausgabe](https://www.msdmanuals.com//-/media/manual/professional/images/3/9/1/391_leukocytoclastic_vasculitis_slide_9_springer_high_de.jpg?thn=0&sc_lang=de)
Eosinophile Granulomatose mit Polyangiitis (EGPA) - Erkrankungen des rheumatischen Formenkreises und des Bewegungsapparats - MSD Manual Profi-Ausgabe
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
![PDF) Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse PDF) Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse](https://i1.rgstatic.net/publication/317485129_Negative_anti-neutrophil_cytoplasm_antibody_at_switch_to_maintenance_therapy_is_associated_with_a_reduced_risk_of_relapse/links/595f3bbdaca2728c11478465/largepreview.png)
PDF) Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
![a) Median GFR during follow-up in diagnostic groups GPA and MPA. For... | Download Scientific Diagram a) Median GFR during follow-up in diagnostic groups GPA and MPA. For... | Download Scientific Diagram](https://www.researchgate.net/publication/328341231/figure/fig5/AS:1086454608470146@1636042372904/a-Median-GFR-during-follow-up-in-diagnostic-groups-GPA-and-MPA-For-up-to-5-years-the_Q640.jpg)
a) Median GFR during follow-up in diagnostic groups GPA and MPA. For... | Download Scientific Diagram
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
![ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia](http://media.medmedia.at/mm_media/fdr/2018/03/Bildschirmfoto_2018-11-05_um_16.02.52_opt.jpg)